The Duchenne muscular dystrophy gene and cancer

L Jones, M Naidoo, LR Machado, K Anthony - Cellular Oncology, 2021 - Springer
Abstract Background Mutation of the Duchenne muscular dystrophy (DMD) gene causes
Duchenne and Becker muscular dystrophy, degenerative neuromuscular disorders that …

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

D Lodygin, V Tarasov, A Epanchintsev, C Berking… - Cell cycle, 2008 - Taylor & Francis
Recently, we and others identified the microRNA miR-34a as a target of the tumor
suppressor gene product p53. Ectopic miR-34a induces a G1 cell cycle arrest, senescence …

Dystrophin is a tumor suppressor in human cancers with myogenic programs

Y Wang, A Marino-Enriquez, RR Bennett, M Zhu… - Nature …, 2014 - nature.com
Many common human mesenchymal tumors, including gastrointestinal stromal tumor (GIST),
rhabdomyosarcoma (RMS) and leiomyosarcoma (LMS), feature myogenic differentiation …

Dystrophin missense mutations alter focal adhesion tension and mechanotransduction

MP Ramirez, MJM Anderson… - Proceedings of the …, 2022 - National Acad Sciences
Dystrophin is an essential muscle protein that contributes to cell membrane stability by
mechanically linking the actin cytoskeleton to the extracellular matrix via an adhesion …

DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome

TA Juratli, D McCabe, N Nayyar, EA Williams… - Acta …, 2018 - Springer
Progressive meningiomas that have failed surgery and radiation have a poor prognosis and
no standard therapy. While meningiomas are more common in females overall, progressive …

From cytogenetics to next-generation sequencing technologies: advances in the detection of genome rearrangements in tumors

O Morozova, MA Marra - Biochemistry and Cell Biology, 2008 - cdnsciencepub.com
Genome rearrangements have long been recognized as hallmarks of human tumors and
have been used to diagnose cancer. Techniques used to detect genome rearrangements …

Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma

GL Gallia, M Zhang, Y Ning, MC Haffner… - Nature …, 2018 - nature.com
Olfactory neuroblastoma (ONB) is a rare malignant neoplasm arising in the upper portion of
the sinonasal cavity. To better understand the genetic bases for ONB, here we perform …

Molecular diagnosis and treatment of meningiomas: an expert consensus (2022)

J Deng, L Hua, L Bian, H Chen, L Chen… - Chinese medical …, 2022 - mednexus.org
Meningiomas are the most common primary intracranial neoplasm with diverse pathological
types and complicated clinical manifestations. The fifth edition of the WHO Classification of …

DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies

WM Schmidt, MH Uddin, S Dysek, K Moser-Thier… - PLoS …, 2011 - journals.plos.org
Albeit genetically highly heterogeneous, muscular dystrophies (MDs) share a convergent
pathology leading to muscle wasting accompanied by proliferation of fibrous and fatty tissue …

Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations

LN Luce, M Abbate, J Cotignola, F Giliberto - Oncotarget, 2016 - pmc.ncbi.nlm.nih.gov
DMD gene mutations have been associated with the development of Dystrophinopathies.
Interestingly, it has been recently reported that DMD is involved in the development and …